Altogether, the data indicated that HNSCC tumors overexpress IL-8 and are positive for the expression of CXCR1 and CXCR2, potentially making this pathway an actionable target in the context of HNSCC. This evidence concerns the gene CXCR2 and head and neck squamous cell carcinoma.